{"count": 10, "results": [{"_id": "33513420", "pmid": 33513420, "title": "Metformin attenuates hyperlipidaemia-associated vascular calcification through anti-ferroptotic effects.", "journal": "Free Radic Biol Med", "authors": ["Ma WQ", "Sun XJ", "Zhu Y", "Liu NF"], "date": "2021-03-01T00:00:00Z", "doi": "10.1016/j.freeradbiomed.2021.01.033", "meta_date_publication": "2021 Mar", "meta_volume": "165", "meta_issue": "", "meta_pages": "229-242", "score": 50277.26, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ attenuates hyperlipidaemia-associated @<m>DISEASE_Vascular_Calcification</m> @DISEASE_MESH:D061205 @@@vascular calcification@@@ through anti-ferroptotic effects.", "citations": {"NLM": "Ma WQ, Sun XJ, Zhu Y, Liu NF. Metformin attenuates hyperlipidaemia-associated vascular calcification through anti-ferroptotic effects. Free Radic Biol Med. 2021 Mar;165():229-242. PMID: 33513420", "BibTeX": "@article{33513420, title={Metformin attenuates hyperlipidaemia-associated vascular calcification through anti-ferroptotic effects.}, author={Ma WQ and Sun XJ and Zhu Y and Liu NF}, journal={Free Radic Biol Med}, volume={165}, pages={229-242}}"}}, {"_id": "36166694", "pmid": 36166694, "title": "Metformin protects against vascular calcification through the selective degradation of Runx2 by the p62 autophagy receptor.", "journal": "J Cell Physiol", "authors": ["Phadwal K", "Koo E", "Jones RA", "Forsythe RO", "Tang K", "Tang Q", "Corcoran BM", "Caporali A", "MacRae VE"], "date": "2022-11-01T00:00:00Z", "doi": "10.1002/jcp.30887", "meta_date_publication": "2022 Nov", "meta_volume": "237", "meta_issue": "11", "meta_pages": "4303-4316", "score": 50266.633, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ protects against @<m>DISEASE_Vascular_Calcification</m> @DISEASE_MESH:D061205 @@@vascular calcification@@@ through the selective degradation of @GENE_RUNX2 @GENE_860 @@@Runx2@@@ by the @GENE_NUP62 @GENE_23636 @@@p62@@@ autophagy receptor.", "citations": {"NLM": "Phadwal K, Koo E, Jones RA, Forsythe RO, Tang K, Tang Q, Corcoran BM, Caporali A, MacRae VE. Metformin protects against vascular calcification through the selective degradation of Runx2 by the p62 autophagy receptor. J Cell Physiol. 2022 Nov;237(11):4303-4316. PMID: 36166694", "BibTeX": "@article{36166694, title={Metformin protects against vascular calcification through the selective degradation of Runx2 by the p62 autophagy receptor.}, author={Phadwal K and Koo E and Jones RA and Forsythe RO and Tang K and Tang Q and Corcoran BM and Caporali A and MacRae VE}, journal={J Cell Physiol}, volume={237}, number={11}, pages={4303-4316}}"}}, {"_id": "38567737", "pmid": 38567737, "title": "Metformin protects against vascular calcification through the selective degradation of Runx2 by the p62 autophagy receptor.", "journal": "J Cell Physiol", "date": "2024-04-03T00:00:00Z", "doi": "10.1002/jcp.31261", "meta_date_publication": "2024 Apr 3", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50266.586, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ protects against @<m>DISEASE_Vascular_Calcification</m> @DISEASE_MESH:D061205 @@@vascular calcification@@@ through the selective degradation of @GENE_RUNX2 @GENE_860 @@@Runx2@@@ by the @GENE_NUP62 @GENE_23636 @@@p62@@@ autophagy receptor.", "citations": {"NLM": "Metformin protects against vascular calcification through the selective degradation of Runx2 by the p62 autophagy receptor. J Cell Physiol. 2024 Apr 3;():. PMID: 38567737", "BibTeX": "@article{38567737, title={Metformin protects against vascular calcification through the selective degradation of Runx2 by the p62 autophagy receptor.}, journal={J Cell Physiol}}"}}, {"_id": "32800550", "pmid": 32800550, "title": "Metformin, resveratrol, and exendin-4 inhibit high phosphate-induced vascular calcification via AMPK-RANKL signaling.", "journal": "Biochem Biophys Res Commun", "authors": ["Lee J", "Hong SW", "Kim MJ", "Kwon H", "Park SE", "Rhee EJ", "Lee WY"], "date": "2020-09-17T00:00:00Z", "doi": "10.1016/j.bbrc.2020.07.136", "meta_date_publication": "2020 Sep 17", "meta_volume": "530", "meta_issue": "2", "meta_pages": "374-380", "score": 50257.836, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, @CHEMICAL_Resveratrol @CHEMICAL_MESH:D000077185 @@@resveratrol@@@, and @CHEMICAL_Exenatide @CHEMICAL_MESH:D000077270 @@@exendin-4@@@ inhibit high @CHEMICAL_Phosphates @CHEMICAL_MESH:D010710 @@@phosphate@@@-induced @<m>DISEASE_Vascular_Calcification</m> @DISEASE_MESH:D061205 @@@vascular calcification@@@ via @GENE_PRKAA2 @GENE_78975 @@@AMPK@@@-@GENE_TNFSF11 @GENE_117516 @@@RANKL@@@ signaling.", "citations": {"NLM": "Lee J, Hong SW, Kim MJ, Kwon H, Park SE, Rhee EJ, Lee WY. Metformin, resveratrol, and exendin-4 inhibit high phosphate-induced vascular calcification via AMPK-RANKL signaling. Biochem Biophys Res Commun. 2020 Sep 17;530(2):374-380. PMID: 32800550", "BibTeX": "@article{32800550, title={Metformin, resveratrol, and exendin-4 inhibit high phosphate-induced vascular calcification via AMPK-RANKL signaling.}, author={Lee J and Hong SW and Kim MJ and Kwon H and Park SE and Rhee EJ and Lee WY}, journal={Biochem Biophys Res Commun}, volume={530}, number={2}, pages={374-380}}"}}, {"_id": "38052777", "pmid": 38052777, "pmcid": "PMC10698150", "title": "Metformin ameliorates valve interstitial cell calcification by promoting autophagic flux", "journal": "Sci Rep", "authors": ["Phadwal K", "Tan X", "Koo E", "Zhu D", "MacRae VE"], "date": "2023-12-05T00:00:00Z", "doi": "10.1038/s41598-023-47774-6", "meta_date_publication": "2023 Dec 5", "meta_volume": "13", "meta_issue": "1", "meta_pages": "21435", "score": 50253.4, "text_hl": "It has previously been established that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ administration reduces @<m>DISEASE_Vascular_Calcification</m> @DISEASE_MESH:D061205 @@@arterial calcification@@@ via autophagy; however, whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ directly regulates @DISEASE_109730 @DISEASE_OMIM:109730 @@@CAVD@@@ has yet to be elucidated. ", "citations": {"NLM": "Phadwal K, Tan X, Koo E, Zhu D, MacRae VE. Metformin ameliorates valve interstitial cell calcification by promoting autophagic flux Sci Rep. 2023 Dec 5;13(1):21435. PMID: 38052777", "BibTeX": "@article{38052777, title={Metformin ameliorates valve interstitial cell calcification by promoting autophagic flux}, author={Phadwal K and Tan X and Koo E and Zhu D and MacRae VE}, journal={Sci Rep}, volume={13}, number={1}, pages={21435}}"}}, {"_id": "34046440", "pmid": 34046440, "pmcid": "PMC8144331", "title": "AMPK: Potential Therapeutic Target for Vascular Calcification", "journal": "Front Cardiovasc Med", "authors": ["Lu Y", "Yuan T", "Min X", "Yuan Z", "Cai Z"], "date": "2021-05-11T00:00:00Z", "doi": "10.3389/fcvm.2021.670222", "meta_date_publication": "2021", "meta_volume": "8", "meta_issue": "", "meta_pages": "670222", "score": 50253.336, "text_hl": "The @<m>DISEASE_Vascular_Calcification</m> @DISEASE_MESH:D061205 @@@VC@@@ progression in the coronary artery and peripheral artery was inhibited by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ usage. ", "citations": {"NLM": "Lu Y, Yuan T, Min X, Yuan Z, Cai Z. AMPK: Potential Therapeutic Target for Vascular Calcification Front Cardiovasc Med. 2021;8():670222. PMID: 34046440", "BibTeX": "@article{34046440, title={AMPK: Potential Therapeutic Target for Vascular Calcification}, author={Lu Y and Yuan T and Min X and Yuan Z and Cai Z}, journal={Front Cardiovasc Med}, volume={8}, pages={670222}}"}}, {"_id": "28202017", "pmid": 28202017, "pmcid": "PMC5311847", "title": "Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients", "journal": "Cardiovasc Diabetol", "authors": ["Mary A", "Hartemann A", "Liabeuf S", "Aubert CE", "Kemel S", "Salem JE", "Cluzel P", "Lenglet A", "Massy ZA", "Lalau JD", "Mentaverri R", "Bourron O", "Kamel S"], "date": "2017-02-15T00:00:00Z", "doi": "10.1186/s12933-017-0509-7", "meta_date_publication": "2017 Feb 15", "meta_volume": "16", "meta_issue": "1", "meta_pages": "24", "score": 50094.477, "text_hl": "Recent preclinical data suggest that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ inhibits @<m>DISEASE_Vascular_Calcification</m> @DISEASE_MESH:D061205 @@@VC@@@ both in vitro and in animal models. ", "citations": {"NLM": "Mary A, Hartemann A, Liabeuf S, Aubert CE, Kemel S, Salem JE, Cluzel P, Lenglet A, Massy ZA, Lalau JD, Mentaverri R, Bourron O, Kamel S. Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients Cardiovasc Diabetol. 2017 Feb 15;16(1):24. PMID: 28202017", "BibTeX": "@article{28202017, title={Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients}, author={Mary A and Hartemann A and Liabeuf S and Aubert CE and Kemel S and Salem JE and Cluzel P and Lenglet A and Massy ZA and Lalau JD and Mentaverri R and Bourron O and Kamel S}, journal={Cardiovasc Diabetol}, volume={16}, number={1}, pages={24}}"}}, {"_id": "29716795", "pmid": 29716795, "title": "Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.", "journal": "Kidney Int", "authors": ["Neven E", "Vervaet B", "Brand K", "Gottwald-Hostalek U", "Opdebeeck B", "De Maré A", "Verhulst A", "Lalau JD", "Kamel S", "De Broe ME", "D'Haese PC"], "date": "2018-07-01T00:00:00Z", "doi": "10.1016/j.kint.2018.01.027", "meta_date_publication": "2018 Jul", "meta_volume": "94", "meta_issue": "1", "meta_pages": "102-113", "score": 50063.656, "text_hl": "To study a possible direct effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on the development of @<m>DISEASE_Vascular_Calcification</m> @DISEASE_MESH:D061205 @@@vascular calcification@@@, independent of its effect on renal function, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (200 mg/kg/day) or vehicle was dosed for ten weeks to @SPECIES_10116 @@@rats@@@ with @CHEMICAL_Warfarin @CHEMICAL_MESH:D014859 @@@warfarin@@@-induced @<m>DISEASE_Vascular_Calcification</m> @DISEASE_MESH:D061205 @@@vascular calcification@@@. ", "citations": {"NLM": "Neven E, Vervaet B, Brand K, Gottwald-Hostalek U, Opdebeeck B, De Maré A, Verhulst A, Lalau JD, Kamel S, De Broe ME, D'Haese PC. Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder. Kidney Int. 2018 Jul;94(1):102-113. PMID: 29716795", "BibTeX": "@article{29716795, title={Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.}, author={Neven E and Vervaet B and Brand K and Gottwald-Hostalek U and Opdebeeck B and De Maré A and Verhulst A and Lalau JD and Kamel S and De Broe ME and D'Haese PC}, journal={Kidney Int}, volume={94}, number={1}, pages={102-113}}"}}, {"_id": "24025223", "pmid": 24025223, "title": "Metformin inhibits vascular calcification in female rat aortic smooth muscle cells via the AMPK-eNOS-NO pathway.", "journal": "Endocrinology", "authors": ["Cao X", "Li H", "Tao H", "Wu N", "Yu L", "Zhang D", "Lu X", "Zhu J", "Lu Z", "Zhu Q"], "date": "2013-10-01T00:00:00Z", "doi": "10.1210/en.2013-1002", "meta_date_publication": "2013 Oct", "meta_volume": "154", "meta_issue": "10", "meta_pages": "3680-9", "score": 50061.215, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ inhibits @<m>DISEASE_Vascular_Calcification</m> @DISEASE_MESH:D061205 @@@vascular calcification@@@ in female @SPECIES_10116 @@@rat@@@ aortic smooth muscle cells via the @GENE_PRKAA2 @GENE_78975 @@@AMPK@@@-@GENE_NOS3 @GENE_24600 @@@eNOS@@@-NO pathway.", "citations": {"NLM": "Cao X, Li H, Tao H, Wu N, Yu L, Zhang D, Lu X, Zhu J, Lu Z, Zhu Q. Metformin inhibits vascular calcification in female rat aortic smooth muscle cells via the AMPK-eNOS-NO pathway. Endocrinology. 2013 Oct;154(10):3680-9. PMID: 24025223", "BibTeX": "@article{24025223, title={Metformin inhibits vascular calcification in female rat aortic smooth muscle cells via the AMPK-eNOS-NO pathway.}, author={Cao X and Li H and Tao H and Wu N and Yu L and Zhang D and Lu X and Zhu J and Lu Z and Zhu Q}, journal={Endocrinology}, volume={154}, number={10}, pages={3680-9}}"}}, {"_id": "26772768", "pmid": 26772768, "title": "Metformin alleviates vascular calcification induced by vitamin D3 plus nicotine in rats via the AMPK pathway.", "journal": "Vascul Pharmacol", "authors": ["Zhang X", "Xiao J", "Li R", "Qin X", "Wang F", "Mao Y", "Liang W", "Sheng X", "Guo M", "Song Y", "Ji X"], "date": "2016-06-01T00:00:00Z", "doi": "10.1016/j.vph.2016.01.002", "meta_date_publication": "2016 Jun", "meta_volume": "81", "meta_issue": "", "meta_pages": "83-90", "score": 50058.703, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ alleviates @<m>DISEASE_Vascular_Calcification</m> @DISEASE_MESH:D061205 @@@vascular calcification@@@ induced by @CHEMICAL_Cholecalciferol @CHEMICAL_MESH:D002762 @@@vitamin D3@@@ plus @CHEMICAL_Nicotine @CHEMICAL_MESH:D009538 @@@nicotine@@@ in @SPECIES_10116 @@@rats@@@ via the @GENE_PRKAA2 @GENE_78975 @@@AMPK@@@ pathway.", "citations": {"NLM": "Zhang X, Xiao J, Li R, Qin X, Wang F, Mao Y, Liang W, Sheng X, Guo M, Song Y, Ji X. Metformin alleviates vascular calcification induced by vitamin D3 plus nicotine in rats via the AMPK pathway. Vascul Pharmacol. 2016 Jun;81():83-90. PMID: 26772768", "BibTeX": "@article{26772768, title={Metformin alleviates vascular calcification induced by vitamin D3 plus nicotine in rats via the AMPK pathway.}, author={Zhang X and Xiao J and Li R and Qin X and Wang F and Mao Y and Liang W and Sheng X and Guo M and Song Y and Ji X}, journal={Vascul Pharmacol}, volume={81}, pages={83-90}}"}}]}